Medicine Status
Terazosin 2 mg Oral Capsule
Pill Identifier
Medicine Status
About Medicine Status
Copyright © 2020 and Spring Launch Media LLC. All Rights Reserved.

All content on this website ("the Site") is the property of Spring Launch Media LLC. The collection and assembly of content on this Site are the exclusive property of Spring Launch Media LLC and are protected by copyright and other intellectual property laws. does not provide medical advice, diagnosis, or treatment, and urges you to consult with a qualified medical provider for diagnosis, treatment, and for answers to your medical questions. does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information disclosed. does not assume any responsibility for any aspect of medical care administered based on the contents provided on this Site. The contents of, such as text, images, graphics, or other material are solely for informational purposes. does not recommend or endorse any specific provider, opinions, procedures, or other information on the Site. Rely on any information provided by or displayed on this Site solely at your own risk. Consult a healthcare professional before taking any drug, choosing or changing any course of treatment.

Terazosin 2 mg Oral Capsule

Pill Finder Wizard
Overview Terazosin 2 mg Oral Capsule is a capsule shaped, whitepill that is approximately 16 mm in size. It has one score and can be broken into two pieces.

It is imprinted with "TL384" and is supplied by Remedyrepack Inc. .
Drug Name Terazosin
Dosage Form Capsule
Imprint(s) TL384
Pill Size 16 mm
DEA Schedule (Potential for Drug Abuse)
Drug Ingredients
Active Ingredient(s) Terazosin Hydrochloride
Inactive Ingredient(s) Gelatin, Lactose Monohydrate, Magnesium Stearate, Sodium Lauryl Sulfate, Titanium Dioxide, Starch, Corn, Colloidal Silicon Dioxide, D&C Yellow No. 10
Drug Codes
RxNorm Concept Unique Identifier 313,217
National Drug Code 242360669
Marketing Category ANDA
Supplier Remedyrepack Inc.
References The data for Terazosin 2 mg Oral Capsule was updated by the U.S National Library of Medicine on October 17, 2017.

  • U.S. National Library of Medicine. Accessed June 8, 2019.
  • Drug Scheduling. United States Drug Enforcement Administration. Accessed June 8, 2019.
  • Structured Product Labeling Resources. U.S. Food & Drug Administration. March 27, 2018. Accessed June 8, 2019.
  • HL7 Reference Information Model. HL7 Interational. Accessed June 8, 2019.